SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stock Watcher's Thread / Pix of the Week (POW)
VEEV 290.05-1.8%2:16 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stock Watcher who wrote (21371)12/11/1999 11:36:00 AM
From: TKB  Read Replies (1) of 52051
 
SW POW candidate Sciclone..

SCLN looks like another exception to the rule; you may want to consider posting this one on the thread & making it a Pick of the Week;

definitely, not the typical pie-in-the-sky biotech, "SciClone's lead drug, ZADAXIN, boosts the body's immune system, without any serious side
effects, in the fight against life-threatening diseases such as hepatitis B, hepatitis C, HIV/AIDS
and cancer. ZADAXIN already has been approved in 16 countries, principally for the treatment of
hepatitis B and hepatitis C. SciClone has filed for ZADAXIN marketing approval in 19 additional
countries."

and they have plenty of cash as well; like it...thanx for the alert...enjoy...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext